Literature DB >> 24816066

Synthesis, biological evaluation and molecular docking studies of trans-indole-3-acrylamide derivatives, a new class of tubulin polymerization inhibitors.

Sultan Nacak Baytas1, Nazan Inceler2, Akin Yilmaz3, Abdurrahman Olgac2, Sevda Menevse3, Erden Banoglu2, Ernest Hamel4, Roberta Bortolozzi5, Giampietro Viola5.   

Abstract

In this study, we synthesized a series of trans-indole-3-acrylamide derivatives (3a-k) and investigated their activity for inhibition of cell proliferation against five human cancer cell lines (HeLa, MCF7, MDA-MB-231, Raji and HL-60) by MTT assay. Compound 3e showed significant antiproliferative activity against both the Raji and HL-60 cell lines with IC50 values of 9.5 and 5.1 μM, respectively. Compound 3e also exhibited moderate inhibitory activity on tubulin polymerization (IC50=17 μM). Flow cytometric analysis of cultured cells treated with 3e also demonstrated that the compound caused cell cycle arrest at the G2/M phase in HL-60 and HeLa cells. Moreover, 3e, the most active compound, caused an apoptotic cell death through the activation of caspase-3. Docking simulations suggested that 3e binds to the colchicine site of tubulin.
Copyright © 2014 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Anticancer activity; Apoptosis; Cell cycle arrest; Colchicine binding; Indole; Molecular docking; Synthesis; Tubulin polymerization

Mesh:

Substances:

Year:  2014        PMID: 24816066      PMCID: PMC4091680          DOI: 10.1016/j.bmc.2014.04.027

Source DB:  PubMed          Journal:  Bioorg Med Chem        ISSN: 0968-0896            Impact factor:   3.641


  36 in total

Review 1.  Evaluation of antimitotic agents by quantitative comparisons of their effects on the polymerization of purified tubulin.

Authors:  Ernest Hamel
Journal:  Cell Biochem Biophys       Date:  2003       Impact factor: 2.194

2.  Insight into tubulin regulation from a complex with colchicine and a stathmin-like domain.

Authors:  Raimond B G Ravelli; Benoît Gigant; Patrick A Curmi; Isabelle Jourdain; Sylvie Lachkar; André Sobel; Marcel Knossow
Journal:  Nature       Date:  2004-03-11       Impact factor: 49.962

3.  Synthesis and biological evaluation of indolyl chalcones as antitumor agents.

Authors:  Dalip Kumar; N Maruthi Kumar; Kanako Akamatsu; Eriko Kusaka; Hiroshi Harada; Takeo Ito
Journal:  Bioorg Med Chem Lett       Date:  2010-05-13       Impact factor: 2.823

4.  Synthesis, biological evaluation, and molecular docking studies of cinnamic acyl 1,3,4-thiadiazole amide derivatives as novel antitubulin agents.

Authors:  Xian-Hui Yang; Qing Wen; Ting-Ting Zhao; Jian Sun; Xi Li; Man Xing; Xiang Lu; Hai-Liang Zhu
Journal:  Bioorg Med Chem       Date:  2012-01-05       Impact factor: 3.641

Review 5.  The discovery of a new potential anticancer drug: a case history.

Authors:  Paolo Cozzi
Journal:  Farmaco       Date:  2003-03

6.  Synthesis, biological evaluation, and molecular modeling of cinnamic acyl sulfonamide derivatives as novel antitubulin agents.

Authors:  Yin Luo; Ke-Ming Qiu; Xiang Lu; Kai Liu; Jie Fu; Hai-Liang Zhu
Journal:  Bioorg Med Chem       Date:  2011-07-07       Impact factor: 3.641

7.  Phenylcinnamides as novel antimitotic agents.

Authors:  Benjamin J Leslie; Clinton R Holaday; Tran Nguyen; Paul J Hergenrother
Journal:  J Med Chem       Date:  2010-05-27       Impact factor: 7.446

8.  Design, synthesis, and evaluation of novel boronic-chalcone derivatives as antitumor agents.

Authors:  Srinivas K Kumar; Erin Hager; Catherine Pettit; Hallur Gurulingappa; Nancy E Davidson; Saeed R Khan
Journal:  J Med Chem       Date:  2003-07-03       Impact factor: 7.446

9.  Synthesis and biological evaluation of enantiomerically pure cyclopropyl analogues of combretastatin A4.

Authors:  Nancy Ty; Renée Pontikis; Guy G Chabot; Emmanuelle Devillers; Lionel Quentin; Stéphane Bourg; Jean-Claude Florent
Journal:  Bioorg Med Chem       Date:  2012-12-21       Impact factor: 3.641

10.  Bisphosphonates induce apoptosis in human breast cancer cell lines.

Authors:  S G Senaratne; G Pirianov; J L Mansi; T R Arnett; K W Colston
Journal:  Br J Cancer       Date:  2000-04       Impact factor: 7.640

View more
  4 in total

1.  Synthesis of novel isoxazole-carboxamide derivatives as promising agents for melanoma and targeted nano-emulgel conjugate for improved cellular permeability.

Authors:  Mohammed Hawash; Nidal Jaradat; Ahmad M Eid; Ahmad Abubaker; Ola Mufleh; Qusay Al-Hroub; Shorooq Sobuh
Journal:  BMC Chem       Date:  2022-06-24

2.  Synthesis of novel indole-isoxazole hybrids and evaluation of their cytotoxic activities on hepatocellular carcinoma cell lines.

Authors:  Mohammed Hawash; Deniz Cansen Kahraman; Sezen Guntekin Ergun; Rengul Cetin-Atalay; Sultan Nacak Baytas
Journal:  BMC Chem       Date:  2021-12-20

3.  Design, synthesis and biological evaluation of novel 1,3-diarylpyrazoles as cyclooxygenase inhibitors, antiplatelet and anticancer agents.

Authors:  Nazan Inceler; Yesim Ozkan; Nilufer Nermin Turan; Deniz Cansen Kahraman; Rengul Cetin-Atalay; Sultan Nacak Baytas
Journal:  Medchemcomm       Date:  2018-04-06       Impact factor: 3.597

4.  Synthesis and cellular bioactivities of novel isoxazole derivatives incorporating an arylpiperazine moiety as anticancer agents.

Authors:  Burcu Çalışkan; Esra Sinoplu; Kübra İbiş; Ece Akhan Güzelcan; Rengül Çetin Atalay; Erden Banoglu
Journal:  J Enzyme Inhib Med Chem       Date:  2018-12       Impact factor: 5.051

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.